01099.HK
Sinopharm Group Co. Ltd.
HKSE · Healthcare · Medical - Distribution · CN
HKD 15.92
−0.25%Year over year
Reported trailing growth
- Revenue
- -1.4%
- EBITDA
- +0.1%
- EBIT
- +10.9%
- EPS
- +3.2%
- Free cash flow
- +14.5%
- Operating cash flow
- +9.4%
Forward estimates
Based on analyst estimates
- Revenue
- +3.7%
- EBITDA
- -34.2%
- EPS
- -2.2%
Three-year CAGR
- Revenue
- +1.4%
- EBITDA
- -6.4%
- EBIT
- -8.0%
- Net income
- -5.7%
- EPS
- -5.7%
- Free cash flow
- -12.3%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026